Pakistan reverses decision to allow uncapped prices for COVID-19 vaccines imported by private firms
ISLAMABAD: Pakistan has reversed a decision which had allowed uncapped prices for COVID-19 vaccines imported by private firms, Health Minister Faisal Sultan said on Thursday (Mar 18).
Pakistan, largely reliant on the GAVI/WHO COVAX initiative for poorer nations, had early iin February allowed private companies to import coronavirus vaccines and agreed to exempt such imports from price caps.
READ: Pakistan receives 500,000 COVID-19 vaccine doses from China, doubling available supply
READ: Pakistan lab expects doses of Sputnik V COVID-19 vaccine for commercial sale in a week
“Now, however, there is a formula, already in vogue, to determine max price,” Sultan told Reuters. “So yes, there is a price cap that DRAP (Drug Regulatory Authority of Pakistan) will recommend and get approval for,” he said.
BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments
Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram
